Month

Your search for 04/2015 returned 35 results.


Two DAA regimen effective in difficult to treat HCV

Regimen of two direct-acting oral antivirals appears effective in patients with difficult to treat HCV subgenotypes 1a and 2b Therapies for HCV genotype 1, 2, and 3 infection have traditionally been peginterferon (pegIFN)-based. PegIFN is associated with adverse events including influenza-like symptoms and depression. Many patients decline PegIFN therapy, and a ...

Read More


Hepatitis C related complications are increasing!

Hepatitis C-related complications substantially increased between 2005 and 2009: patients with HCV are getting sicker Of all the people in the US living with hepatitis C (HCV), an estimated 76% are adults born during 1945 to 1965: a generation known as the Baby Boomers. A sizeable percentage of Baby Boomers are unaware of their infection status, and given that ...

Read More


Can hepatitis C be eradicated in the US?

An important commentary by Brian Edlin and Emily Winkelstein, published in August 2014 in the journal Antiviral Research, outlined key steps that should be taken to accomplish the elimination of hepatitis C in the United States (Edlin BR, Winkelstein ER. Antiviral Res. 2014;110:79-93). This article is freely available on the online AJM Hepatitis C Resource Center ...

Read More


Rapid HCV testing in jails: linkage to care barrier

Rapid HCV testing within jails identifies previously unrecognized cases of HCV infection, but linkage to care after release is a major barrier One-third of all HCV-infected individuals in the USA pass through the criminal justice system each year, so at any given time the correctional population in the USA bears a heavy burden of HCV infection. HCV antibody ...

Read More


HCV RNA Testing in HCV Seropositive Patients

Only 48% of HCV Seropositive Patients Undergo HCV RNA Testing and Only 5% Initiate Therapy The Centers for Disease Control and Prevention recommends one-time hepatitis C virus (HCV) testing of individuals born between 1945 and 1965, with follow-up RNA testing for those with reactive serology. A study published last year in the journal Open Forum Infectious ...

Read More